MDGL

Madrigal Pharmaceuticals
D

MDGL

513.66
USD
0.21
(0.04%)
مغلق
حجم التداول
29,196
الربح لكل سهم
-7
العائد الربحي
-
P/E
-38
حجم السوق
11,842,769,802
أصول ذات صلة المقالات
المزيد

العنوان: Madrigal Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.